General Updates

August 01, 2026 BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, Exchange Plaza, Plot No. C/1, G Block Mumbai- 400 001 Bandra-Kurla Complex, Bandra (E) Mumbai- 400 051 Scrip ID-540025 Scrip Code-ADVENZYMES Dear Sir/Madam, Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref.: Outcome of Board Meeting intimation dated May 09, 2026; and voting results of the Annual General meeting of the Company held on July 31, 2026 The Members of the Company at its 37th Annual General Meeting (“AGM”) held on July 31, 2026 approved the appointment/re-appointment of the following (as per the Scrutinizer’s report, all the resolutions passed with the requisite majority): i) Re-appointment of Mr. Mukund Madhusudan Kabra (DIN- 00148294) as Whole Time Director of the Company for another term of five years effective from April 01, 2027 to March 31, 2032. ii) Appointment of Mr. Pradip Bhailal Shah (DIN- 01225582) as an Independent Director for a term of five consecutive years up to June 11, 2031. iii) Re-appointment of M S K A & Associates LLP, Chartered Accountants (FRN: 105047W/W101187) as the Statutory Auditors of the Company for a second term of five consecutive years from the conclusion of the 37th AGM till the conclusion of the 42nd AGM of the Company to be held for the financial year ended March 31, 2031. The details pertaining to the reappointment/appointment of Directors and reappointment of the Statutory Auditors as required under the provisions of Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirement) Regulations read with Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated July 11, 2023 as amended on January 30, 2026, were provided as an Annexure to the captioned outcome of the Board meeting held on May 09, 2026. Kindly take the same on record. Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head – Legal